Table 2.
HLA alleles of mobilized and non-mobilized donors
| Donor | HLA A | HLA B | HLA C | CMV multimers analyzed | EBV multimers analyzed | |
|---|---|---|---|---|---|---|
| Mobilized | 1 |
A*02:01
A*23:01 |
B*41:02 B*51:01 |
C*14:02 C*17:03 |
A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL |
| 2 |
A*02:01
A*03:01 |
B*18:01 B*27:01 |
C*02:02 C*12:03 |
A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL | |
| 3 |
A*02:01
A*32:01 |
B*13:02 B*40:02 |
C*02:02 C*06:02 |
A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL | |
| 4 | A*02:01 | B*15:02 B*44:02 |
C*03:03 C*05:01 |
A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL | |
| 5 | A*01:01 |
B*35:01
B*49:01 |
C*02:02 C*12:02 |
A1/YSE, A1/VTE, B35/IPS | B35/HPV, B35/EPL, B35/YPL | |
| 6 |
A*01:01
A*03:01 |
B*07:02 | C*07:02 | A1/YSE, A1/VTE, B7/RPH, B7/TPR | B7/RPP | |
| 7 |
A*02
A*24 |
B*13 | C*06 | A2/NLV, A2/VLE | A2/CLG, A2/GLC, A2/YVL | |
| 8 |
A*01:01
A*24:02 |
B*08:01
B35*02 |
C*04:01 C*07:01 |
A1/YSE, A1/VTE, B8/ELK, B8/QIK | B8/RAK, B8/QAK | |
| Non-mobilized | 9 | A*02 |
B*07
B*35 |
C*07 | A2/NLV, A2/VLE, B7/RPH, B7/TPR, B35/IPS, C7/CRV | A2/CLG, A2/GLC, A2/YVL, A2/FLY, B7/RPP, B35/HPV, B35/EPL, B35/YPL |
| 10 |
A*01
A*02 |
B*07
B*08 |
nd | A1/YSE, A1/VTE, A2/NLV, A2/VLE, B7/RPH, B7/TPR, B8/ELK, B8/QIK |
A2/CLG, A2/GLC, A2/YVL, A2/FLY, B7/RPP, B8/RAK, B8/QAK | |
| 11 |
A*02
A*03 |
B*27 B*62 |
nd | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL, A2/FLY | |
| 12 |
A*02
A*03 |
B*15 B*35 |
nd | A2/NLV, A2/VLE, B35/IPS | A2/CLG, A2/GLC, A2/YVL, A2/FLY, B35/HPV, B35/EPL, B35/YPL | |
| 13 |
A*02
A*24 |
B*44 B*51 |
nd | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL, A2/FLY | |
| 14 |
A*02
A*30 |
B*18 B*39 |
C*07 | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL | |
| 15 |
A*02
A*26 |
B*07 | C*06 C*07 |
A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL | |
| 16 | A*02 |
B*07
B*08 |
C*07 | A2/NLV, A2/VLE, | A2/CLG, A2/GLC, A2/YVL |
Peptide-pool compatible HLA alleles are listed in italic. Multimers which were available at the time and therefore used for analysis are listed for each donor in the two last columns